Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Regeneron Pharmaceuticals logoRegeneron Pharmaceuticals REGN

The company said shareholders elected 4 Class I directors at its June 13, 2025 annual meeting to serve until the 2028 annual meeting. Leonard S. Schleifer received 99,271,439 votes in favor, and George D. Yancopoulos received 101,367,161 votes in favor.

8-KSubmission of Matters to a Vote of Security HoldersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said shareholders elected 4 Class I directors at its June 13, 2025 annual meeting to serve until the 2028 annual meeting. Leonard S. Schleifer received 99,271,439 votes in favor, and George D. Yancopoulos received 101,367,161 votes in favor.

  2. The company said shareholders approved the selection of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2025 with 105,462,255 votes in favor. It said the advisory vote on executive compensation also passed with 98,781,758 votes in favor.

  3. The company said shareholders approved the charter amendment to declassify the board of directors with 85,711,231 votes in favor, 20,226,748 against and 56,300 abstentions. It said there were 5,601,648 broker non-votes.

  4. The company said none of the 2 charter amendments to eliminate supermajority vote requirements was approved. For the Class A stock conversion amendment under Proposal 5(a), Class A stock voted 0 in favor and 18,081,400 against, and for the amendment on removal of directors for cause under Proposal 5(b), the vote was 85,490,182 in favor and 20,360,243 against.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Regeneron elects 4 Class I directors at June 13, 2025 annual meeting

The company said shareholders elected 4 Class I directors at its June 13, 2025 annual meeting to serve until the 2028 annual meeting. Leonard S. Schleifer received 99,271,439 votes in favor, and George D. Yancopoulos received 101,367,161 votes in favor.

Source · Based on the filing body and exhibits

Shareholders approve PricewaterhouseCoopers auditor and say-on-pay

The company said shareholders approved the selection of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2025 with 105,462,255 votes in favor. It said the advisory vote on executive compensation also passed with 98,781,758 votes in favor.

Source · Based on the filing body and exhibits

Shareholders approve charter amendment to declassify board

The company said shareholders approved the charter amendment to declassify the board of directors with 85,711,231 votes in favor, 20,226,748 against and 56,300 abstentions. It said there were 5,601,648 broker non-votes.

Source · Based on the filing body and exhibits

2 supermajority charter amendments not approved

The company said none of the 2 charter amendments to eliminate supermajority vote requirements was approved. For the Class A stock conversion amendment under Proposal 5(a), Class A stock voted 0 in favor and 18,081,400 against, and for the amendment on removal of directors for cause under Proposal 5(b), the vote was 85,490,182 in favor and 20,360,243 against.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.